Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes-Reference-Cited by-同舟云学术

Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes

Published:2016-02-23 Issue: Volume:9 Page:
ISSN:1662-5099
Container-title:Frontiers in Molecular Neuroscience
language:
Short-container-title:Front. Mol. Neurosci.

Author:

von Jonquieres Georg,Fröhlich Dominik,Klugmann Claudia B.,Wen Xin,Harasta Anne E.,Ramkumar Roshini,Spencer Ziggy H. T.,Housley Gary D.,Klugmann Matthias

Funder

National Health and Medical Research Council

Publisher

Frontiers Media SA

Subject

Cellular and Molecular Neuroscience,Molecular Biology

Reference45 articles.

1. A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS gene therapy in Canavan mice;Ahmed;Mol. Ther.,2013

2. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy;Biffi;Science,2013

3. MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes;Bujalka;PLoS Biol.,2013

4. A transcriptome database for astrocytes, neurons and oligodendrocytes: a new resource for understanding brain development and function;Cahoy;J. Neurosci.,2008

5. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy;Cartier;Science,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AAV-α-Synuclein Model of Parkinson’s Disease: An Update;Journal of Parkinson's Disease;2024-09-03

2. Glial cells as a promising therapeutic target of glaucoma: beyond the IOP;Frontiers in Ophthalmology;2024-01-08

3. Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders;Advanced Science;2023-06-04

4. Recessive aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models;Frontiers in Neuroscience;2023-05-09

5. Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice;Frontiers in Molecular Neuroscience;2022-12-08